Search Results

Apaziquone 5mg 5mg  | Purity Not Available

Adooq Bioscience

Apaziquone is an indolequinone bioreductive prodrug and analog of mitomycin C with potential antineoplastic and radiosensitization activities.

More Information Supplier Page

Apaziquone 25mg 25mg  | Purity Not Available

Adooq Bioscience

Apaziquone is an indolequinone bioreductive prodrug and analog of mitomycin C with potential antineoplastic and radiosensitization activities.

More Information Supplier Page

Apaziquone 100mg 100mg  | Purity Not Available

Adooq Bioscience

Apaziquone is an indolequinone bioreductive prodrug and analog of mitomycin C with potential antineoplastic and radiosensitization activities.

More Information Supplier Page

MifaMurtide 10mg 10mg  | Purity Not Available

Adooq Bioscience

Mifamurtide is a liposomal formulation containing a muramyl dipeptide (MDP) analogue with potential immunomodulatory and antineoplastic activities

More Information Supplier Page

AZD3514 10mg 10mg  | Purity Not Available

Adooq Bioscience

AZD-3514 is a potent androgen receptor downregulator with potential anticancer cancer activity.

More Information Supplier Page

XL388 5mg 5mg  | Purity Not Available

Adooq Bioscience

XL388 is a Novel Class of Highly Potent, Selective, ATP-Competitive, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin (mTOR).

More Information Supplier Page

XL388 25mg 25mg  | Purity Not Available

Adooq Bioscience

XL388 is a Novel Class of Highly Potent, Selective, ATP-Competitive, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin (mTOR).

More Information Supplier Page

XL388 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

XL388 is a Novel Class of Highly Potent, Selective, ATP-Competitive, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin (mTOR).

More Information Supplier Page